A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.
Clinical trial NCT00197041 · COMPLETED
Trial details
- NCT number
- NCT00197041
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2005-04-01
- Enrollment
- 2022
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.